Treatment Resistance Overview
Overview of treatment-resistance, progression-pattern, and cross-cancer treatment-escape topics
Last updated
Was this helpful?
Overview of treatment-resistance, progression-pattern, and cross-cancer treatment-escape topics
This section gathers cross-cancer treatment-resistance topics in one place.
Use it when the main question is about why treatment may stop working, not just what symptom it causes.
Treatment Resistance Cross-cancer resistance mechanisms, progression patterns, pharmacokinetic questions, and treatment-escape logic.
Dormant Cancer Cells Cross-cancer guide to dormancy, residual disease, reactivation risk, and treatment strategy questions.
Senescence — The Second Escape Route Hub for therapy-induced senescence, SASP biology, senolytic strategy, and safety questions.
Drug Metabolism & Supplement Interactions Shared pharmacokinetic, transporter, supplement-interaction, and drug-exposure questions.
why treatment may have stopped working
whether progression reflects tumour biology or drug exposure
how biomarkers or metabolism may change next steps
how dormancy, residual disease, or resistance escape may fit the picture
how therapy-induced senescence or senolytic follow-up may fit the picture
how supplement use, enzyme pathways, or metabolism may affect drug exposure
For symptom burden, side-effect interpretation, and recovery support, use the separate Side Effects Overview.
Some related pages sit beside this hub rather than inside it:
This hub now stands on its own.
More resistance pages can be added here without being mixed into side-effect navigation.
This information is for education only. It is not medical advice, diagnosis, or treatment. Please speak with a qualified clinician before making changes to care, medication, or supplement use.
© 2026 Abbey Mitchell. All rights reserved. Please share by URL rather than copying page text.
Last updated
Was this helpful?
Was this helpful?